Latest Financial Reports News

ECP Emerging Growth Limited has reported a stable financial position for its convertible notes in Q3 2025, with a loan-to-value ratio of just 21.54% and no changes to the conversion price.

Superior Resources Limited clarifies recent share price jump, attributing it to soaring gold prices and imminent resource updates, while confirming no undisclosed information.

MedAdvisor Limited will have its trading suspension lifted on 10 October 2025 following the lodgement of its annual financial report, marking a key moment for investors.

Wellard Limited has formally requested to delist from the ASX following the sale of its final revenue-generating vessel, aiming to reduce costs and return excess cash to shareholders. The move awaits shareholder approval at the upcoming AGM.

Seafarms Group Limited has resumed trading on the ASX following the lifting of its suspension, triggered by the lodgement of its annual financial report.

Assetora Limited has released its audited FY25 financial report showing a significant reduction in losses and a strengthened capital position, highlighted by the reopening of the DomaCom Fund and a $3 million private placement. The company aims to leverage these developments to accelerate growth in funds under management.

Jayride Group Limited’s shares have been suspended from trading on the ASX following concerns over its financial health and a critical auditor’s disclaimer. The suspension highlights significant regulatory scrutiny and investor risk.

DigitalX Limited has responded to ASX queries, affirming the legality of its cryptocurrency treasury strategy and outlining plans to expand Bitcoin holdings significantly by 2027 to support its digital asset business.

European Lithium Limited will lift its trading suspension on 3 October 2025 following the release of its Annual Financial Report, marking a key milestone for investors.

CONNEQT Health has disclosed significant revisions to its 2025 financial results, highlighting increased losses driven by a larger-than-expected fair value write-down on its inHealth investment and a heightened inventory provision.

Aurum Resources Limited has had its trading suspension lifted immediately following the lodgement of its annual financial report, allowing its shares to resume trading on the ASX.

Memphasys Limited has announced a pro-rata entitlement offer to raise approximately $1.12 million, issuing new shares at $0.003 each with free attaching options, aiming to fund the commercialisation of its Felix™ system and strengthen working capital.